| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5950435 | Atherosclerosis | 2011 | 7 Pages |
Abstract
Both atorvastatin and rosuvastatin cause comparable reductions of thromboxane-dependent platelet activation, lipid peroxidation and inflammation. The presence of 3â²UTR/LOX-1 polymorphism does not affect the changes induced by either statin.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Luca Puccetti, Francesca Santilli, Anna Laura Pasqui, Stefano Lattanzio, Rossella Liani, Federica Ciani, Elisabetta Ferrante, Giovanni Ciabattoni, Francesca Scarpini, Anna Ghezzi, Alberto Auteri, Giovanni Davì,